This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Ying Li-Sommer: Innovator in Pharmaceutical Compounds
Introduction
Ying Li-Sommer is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Ying Li-Sommer holds a patent for "Substituted tricyclic compounds and methods of use thereof." This invention relates to novel compounds and processes for their preparation. It also includes methods of treating diseases, particularly cancer, by administering these compounds. Furthermore, it outlines methods for creating pharmaceutical compositions aimed at the treatment or prevention of disorders, especially cancer.
Career Highlights
Ying Li-Sommer is associated with Bayer Intellectual Property GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His role at Bayer allows him to collaborate with other experts and contribute to groundbreaking research.
Collaborations
Ying Li-Sommer has worked alongside notable colleagues such as Hartmut Schirok and Michael Brands. Their combined expertise fosters a collaborative environment that enhances the potential for innovative breakthroughs in their field.
Conclusion
Ying Li-Sommer's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a key inventor in the industry. His patent and ongoing work at Bayer Intellectual Property GmbH reflect his commitment to improving healthcare through scientific advancements.